HRTX 악천후가 수술에 미치는 영향
제한된 보도로 새로운 내러티브가 형성 중입니다.
심리 타임라인
이벤트 타임라인
가설
HRTX gross margin will compress by 150-250 basis points in Q1 2026 due to weather-related operational inefficiencies and fixed cost absorption over lower procedure volumes, with margin recovery of 100+ basis points by Q2 2026.
HRTX stock price will experience 5-15% downside within 10 trading days following Q1 2026 earnings announcement due to weather-related revenue miss and reduced guidance, followed by 8-12% recovery within 60 days as management provides mitigation strategy.
Severe weather impact on HRTX Q1 2026 surgical procedures will result in revenue decline of 8-12% compared to Q4 2025, with recovery expected by Q3 2026 as operational capacity normalizes.